American Society of Hirudotherapy

Spontaneous intramural small bowel hematoma: unusual cause of intestinal subocclusion in an anticoagulated patient-a case report

Case report published in AME case reports (2026)

Last Updated: November 1, 2026ASH Editorial · based on the books
Research article — evidence review: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.Article reference: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.
Evidence: Case reportClinical LiteratureCalomeni et al. · AME case reports, 2026

Abstract

BACKGROUND: Spontaneous intramural small bowel hematoma (SISBH) is a rare complication of long-term oral anticoagulation, particularly with vitamin K antagonists (VKAs). SISBH diagnosis is based on oral anticoagulation history associated with acute abdominal symptoms and suggestive radiological findings. Experience with this condition is still limited in the literature. This report highlights the clinical presentation and management of this rare condition, including the first known use of total-body positron emission tomography/computed tomography (PET/CT) scan in the diagnostic workup of SISBH. CASE DESCRIPTION: A 53-year-old male on long-term oral anticoagulation with VKA for mechanical mitral valve replacement due to rheumatic heart disease presented to the emergency department for abdominal pain and nausea. Physical examination was remarkable for abdominal distension, increased bowel sounds and rebound tenderness, a presentation compatible with intestinal subocclusion. At admission, the international normalized ratio was 8.3, indicating VKA intoxication. Abdominal CT revealed significant jejunal parietal thickening, suggestive of SISBH. PET/CT findings were also consistent with a possible hematoma, although an inflammatory or neoplastic process could not be excluded. We opted for conservative treatment with temporary warfarin suspension and vitamin K infusion. The patient's intestinal subocclusion gradually improved, and he was discharged after seven days with full recovery. CONCLUSIONS: SISBH, although rare, should be considered in the differential diagnosis of acute abdominal symptoms in patients receiving long-term oral anticoagulation, particularly with VKAs. Conservative treatment is the preferred initial option. A high index of suspicion, followed by prompt abdominal CT, is key to early diagnosis. PET/CT provided minimal diagnostic value beyond CT. Conservative management with anticoagulation reversal and supportive care is generally the primary therapeutic strategy adopted in the literature, demonstrating favorable short-term outcomes, as was the case with our patient.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeCase ReportsJournal Article

Summary

Case report of a 53-year-old man on long-term vitamin K antagonist therapy who developed a spontaneous intramural small bowel hematoma causing intestinal subocclusion; conservative care with warfarin suspension and vitamin K infusion led to full recovery in seven days.

Context

This single case report describes a 53-year-old man on long-term vitamin K antagonist anticoagulation (for a mechanical mitral valve) who presented with intestinal subocclusion from a spontaneous intramural small-bowel hematoma at a markedly supratherapeutic INR of 8.3, managed conservatively with warfarin suspension and vitamin K reversal to full recovery. It is a sober illustration of the bleeding hazard that defines the entire anticoagulation landscape in which medicinal leech therapy operates: leech saliva delivers its own anticoagulant load (hirudin and related antithrombotics), so the case is a reminder that any anticoagulant effect must be weighed against hemorrhagic risk, and that patients already systemically anticoagulated are a population where adding a bleeding source warrants caution. The caveat is fundamental: this is a single, uncontrolled case report about a VKA complication with no leech involvement whatsoever, so it carries no generalizable evidence and only contextualizes anticoagulation-bleeding tradeoffs rather than informing hirudotherapy practice directly.

Citation

Reference (Vancouver style)

Calomeni P, Correa ES, Araujo DS, Spina GS. Spontaneous intramural small bowel hematoma: unusual cause of intestinal subocclusion in an anticoagulated patient-a case report. AME Case Rep. 2026;10:34. doi:10.21037/acr-2025-108. PMID: 41676185

Bibliographic details (authors, volume, pages, DOI) are taken from the PubMed record.

Added to ASH library: May 28, 2026 · Site last updated: November 1, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.